Genetesis

Genetesis is a commercial-stage medical technology company that is redefining the way clinical diagnosis and classification of myocardial ischemia and coronary artery disease are conducted by combining its non-invasive biomagnetic imaging technology with proprietary cloud-based web services and machine learning capabilities.Genetesis's initial goal is to conduct the ultimate exclusion test in combination with 12-lead ECGs and serial troponins, addressing clinically significant myocardial ischemia in acute care settings. Genetesis has created a unique network microservices architecture called the Faraday Analytics Cloud, which integrates its easy-to-operate and highly available non-invasive biomagnetic imaging device (called the CardioFlux FAC Magnetocardiograph) with powerful proprietary algorithms capable of extracting data from magnetic field maps measured by the device into clinically usable information, seamlessly integrating this information into clinical workflows and revenue cycle management.